ASX:PHX PharmX Technologies (PHX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About PharmX Technologies Stock (ASX:PHX) 30 days 90 days 365 days Advanced Chart Get PharmX Technologies alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield17.86%Price TargetN/AConsensus RatingN/A Company OverviewPharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering gateway; PharmX Marketplace, an online sales and marketing platform; and PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023. PharmX Technologies Limited was incorporated in 1950 and is headquartered in Sydney, Australia.Read More… Receive PHX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmX Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address PHX Stock News HeadlinesPharmX Technologies Ltd (ASX:PHX) (H1 2025) Earnings Call Highlights: Strong Revenue Growth and ...February 19, 2025 | gurufocus.comHalf Year 2025 Pharmx Technologies Ltd Earnings Call TranscriptFebruary 19, 2025 | gurufocus.comWhy America’s building cathedrals againWhile the media fixates on tariffs and market noise, something historic is unfolding behind the scenes. With backing from the White House and Silicon Valley billionaires, a vast network of AI-powered facilities is taking shape across the country. They’re being called “Cathedrals of Light” — and they hold the keys to nuclear fusion, advanced medicine, and defense breakthroughs. I’ve spent 25 years identifying seismic shifts like this — and I believe this could be the biggest one yet for early investors.May 14, 2025 | Porter & Company (Ad)Full Year 2024 Pharmx Technologies Ltd Earnings Call TranscriptSeptember 14, 2024 | gurufocus.comPharmX Technologies Ltd (ASX:PHX) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue ...September 14, 2024 | gurufocus.comSee More Headlines Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryPetroleum And Natural Gas Current SymbolASX:PHX CIKN/A Webpharmx.com.au Phone61-2-8871-8501FaxN/AEmployees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net Margins-21.86% Pretax MarginN/A Return on Equity0.50% Return on Assets0.46% Debt Debt-to-Equity Ratio1.50 Current Ratio1.37 Quick RatioN/A Sales & Book Value Annual Sales$8.09 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.03 per share Price / BookN/AMiscellaneous Outstanding Shares598,510,000Free FloatN/AMarket CapN/A OptionableN/A Beta1.23 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (ASX:PHX) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersThe world’s first multi- trillion-dollar robotics industry …Robots are standing on the edge of history. No one would know this better than Nvidia's Jensen Huang. In...Weiss Ratings | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s third-term comments grabbed headlines, but the bigger story is what he’s planning next. A new report ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmX Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmX Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.